Antidiabetic potential of polyoxotungstates: in vitro and in vivo studies
Open Access
- 1 January 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 6 (8) , 1521-1526
Abstract
Polyoxometalates are structurally diverse inorganic metal complexes capable of treating diabetes and its associated complications, a metabolic disorder continuously affecting people all over the world.Keywords
This publication has 64 references indexed in Scilit:
- Polyoxometalates as potent and selective inhibitors of alkaline phosphatases with profound anticancer and amoebicidal activitiesDalton Transactions, 2012
- Aldose reductase: new insights for an old enzymeBioMolecular Concepts, 2011
- Aldose reductase: A novel therapeutic target for inflammatory pathologiesThe International Journal of Biochemistry & Cell Biology, 2010
- Global and societal implications of the diabetes epidemicNature, 2001
- Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic MouseClinical Immunology and Immunopathology, 1994
- Polyoxometalate Diphosphate Complexes. Folded Macrocyclic Dodecatungstates, [(O3PXPO3)4W12O36]16- (X = O, CH2)Journal of the American Chemical Society, 1994
- AcarboseDrugs, 1993
- Aldose reductase: Congenial and injurious profiles of an enigmatic enzymeBiochemical Medicine and Metabolic Biology, 1992
- A 183W, 1H and 17O nuclear magnetic resonance study of aqueous isopolytungstatesJ. Chem. Soc., Dalton Trans., 1992
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsNew England Journal of Medicine, 1987